It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Hay fever season arrives in Japan amid coronavirus pandemic

National / Science & Health Feb 16, 2021

Hay fever season arrives in Japan amid coronavirus pandemic

The season presents an added challenge amid the pandemic as rubbing itchy eyes and wiping runny noses threaten to boost the risk of viral infection.

WHO approval of AstraZeneca-Oxford vaccine widens access in developing world

World Feb 16, 2021

WHO approval of AstraZeneca-Oxford vaccine widens access in developing world

The WHO's review found that the vaccine met the "must-have" criteria for safety and that its efficacy benefits outweighed its risks.

COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says

World Jan 29, 2021

COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says

The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.

Doctors' and nurses' groups in Japan declare medical emergency

National / Science & Health Dec 22, 2020

Doctors' and nurses' groups in Japan declare medical emergency

In a statement, nine groups called on the government to provide proper assistance to front-line medical workers, and on the public to take thorough steps to prevent infections.

Emmanuel Macron has the same problem as King Louis XVI

Commentary / World Dec 21, 2020

Emmanuel Macron has the same problem as King Louis XVI

by Lionel Laurent

French orders of the Pfizer vaccine run to about 45 million, which means around 22 million people can receive the two-shot course.

Vaccines don’t mean we’ll see the last of COVID-19, experts warn

World / Science & Health Dec 21, 2020

Vaccines don’t mean we’ll see the last of COVID-19, experts warn

by John Lauerman and James Paton

Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.

The coronavirus is mutating. What does that mean for us?

World / Science & Health Dec 21, 2020

The coronavirus is mutating. What does that mean for us?

by Apoorva Mandavilli

It will be very hard for the coronavirus to escape the body’s defenses, despite the many variations it may adopt.

South Korea sets record COVID-19 cases as prison reports major outbreak

Asia Pacific / Science & Health Dec 20, 2020

South Korea sets record COVID-19 cases as prison reports major outbreak

With daily infections over 1,000 for a fifth consecutive day, some medical experts and politicians criticized the government for being too loose with social distancing rules.

Pfizer first drugmaker to seek COVID-19 vaccine approval in Japan

National / Science & Health Dec 18, 2020

Pfizer first drugmaker to seek COVID-19 vaccine approval in Japan

by Osamu Tsukimori

Officials said the approval would be made "a top priority in the screening process" once the firm submits data from an ongoing clinical trial specific to Japan, expected in February.

Government in a muddle over suspended travel campaign

Editorials Dec 17, 2020

Government in a muddle over suspended travel campaign

Researchers found that people who participated in the government's Go To Travel campaign were as much as twice as likely to have COVID-19 symptoms than those who did not.

Japan's review of Avigan as COVID-19 treatment draws blank

National / Science & Health Dec 17, 2020

Japan's review of Avigan as COVID-19 treatment draws blank

The Pharmaceuticals and Medical Devices Agency raised questions about the way tests were performed and the criteria for determining whether symptoms had improved, sources say.

WHO plan risks leaving poor nations with no COVID-19 vaccines until 2024

World Dec 17, 2020

WHO plan risks leaving poor nations with no COVID-19 vaccines until 2024

by Francesco Guarascio

Documents show the program's promoters say it is struggling from a lack of funds, supply risks and complex contractual arrangements which could make it impossible to achieve its goals.

« 1 … 4 5 6 … 122 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times